SOLTEC HEALTH Revenue and Competitors

SOLTEC Health (https://soltechealth.com/) has developed a safe, noninvasive, drug-free platform technology that can greatly expand the already growing field of neuromodulation. With this new disruptive technology, it is now possible to influence a region of the central nervous system, the brainstem, which includes the autonomic nervous system. The technology addresses the #1 health complaint in the U.S. – POOR SLEEP!\n\nDr. Dan Cohen, Founder and CEO, has committed his career to reducing stress and improving sleep. Prior to founding SOLTEC Health, Dr. Cohen founded and led CNS, Inc., best known for the Breathe Right Nasal Strips. In addition, he pioneered computerized sleep disorder diagnostics, which was the catalyst for the increase of sleep labs from 300 to over 3,000. CNS was sold to GlaxoSmithKline for $566MM in 2006.\n\nSOLTEC has independently found evidence, in feasibility human trials, that its approach can mitigate peripheral neuropathy, a diagnosis with generally poor outcomes and few treatment alternatives.